IP Verse

Avencell Europe competitive analysis

Loading summary...

Explore patent oppositions filed by Avencell Europe against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2651442	Universal Anti-Tag Chimeric Antigen Receptor-Expressing T Cells And Methods Of Treating Cancer	UNIVERSITY OF MARYLAND	Jan 20, 2021

Explore the latest publications and patents granted to Avencell Europe, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Avencell Europe, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Avencell Europe with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
AVENCELL EUROPE	1	-	-	-
UNIVERSITY OF MARYLAND	-	4	-	2